您的位置: 首页 > 2025年4月 第56卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

复方黄芪颗粒对小鼠抗疲劳的作用及其机制研究

Study on the anti-fatigue effect of compound Huangqi granules on mice and its mechanism

来源期刊: 广州医药 | 509-515 发布时间:2025-04-20 收稿时间:2025/5/8 17:42:30 阅读量:66
作者:
关键词:
复方黄芪颗粒抗疲劳抗氧化机制
compound Huangqi granulesanti-fatigueanti-oxidationmechanism
DOI:
10. 20223 / j. cnki. 1000-8535. 2025. 04. 011
收稿时间:
2024-05-06 
修订日期:
 
接收日期:
 
引用总数:
1  
       目的   探讨复方黄芪颗粒(CHG)的抗疲劳作用及其机制。方法  48只雄性BALB/C小鼠随机分为空白对照组、低剂量(9.1 g/kg)、中剂量(18.2 g/kg)、高剂量(27.3 g/kg)CHG 3个试验组,每组12只。试验组给予不同剂量的复方黄芪颗粒溶液灌胃,空白对照组小鼠给予等体积生理盐水。给药30 d后,检测小鼠体内相关指标变化,观察其抗疲劳作用并分析相关机制。结果   与空白对照组相比,试验组小鼠体质量差异无统计学意义(P>0.05),小鼠力竭游泳时间及转棒耐力时间均明显延长(P<0.01),血尿素氮(BUN)、乳酸脱氢酶(LDH)、丙二醛(MDA)水平明显降低P<0.01),肝糖原和肌糖原水平升高(P<0.05),超氧化物歧化酶(SOD)活性升高(P<0.01)。体外抗氧化试验表明CHG以剂量依赖性方式清除2,2-联氮-二(3-乙基-苯并噻唑-6-磺酸)二铵盐(ABTS)和1,1-二苯基-2-三硝基苯肼(DPPH)自由基。当CHG质量浓度为100.000 0 mg/mL时,CHG对DPPH自由基清除能力可达85.030 3%。当CHG质量浓度为25.000 0 mg/mL时,CHG对ABTS自由基清除能力可达96.357 2%。结论  CHG具有抗疲劳的作用,其作用机制可能与抗氧化作用相关。
      Objective  To investigate the anti-fatigue effects of compound Huangqi granules(CHG)and its mechanism.Methods  Forty-eight male BALB/C mice were randomly divided into blank control group,9.1,18.2,27.3 g/kg CHG group(test groups).The test groups received different concentrations of CHG solution by gavage,and the blank control group mice were given equal volume saline.After 30 days of administration,the mice were tested,meanwhile the anti-fatigue effect and mechanism were investigated.Results  Compared with blank control group,there was no significant difference in body weight(P>0.05).The exhaustive swimming time and rod turning endurance time of mice were significantly prolonged(P<0.01).The serum levels of blood urea nitrogen,lactate dehydrogenase and malondialdehyde were significantly decreased(P<0.01),while the liver and muscle glycogen levels(P<0.05)and superoxide dismutase activity were increased(P<0.01).In vitro antioxidant tests showed that CHG can remove (1,1-Diphenyl-2-picrylhydrazyl,ABTS) and (2,2’-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid,DPPH) free radicals in a dose-dependent manner.When the CHG concentration is 100 mg/mL,the DPPH free  radical scavenging ability of CHG can reach 85.030 3%.When the CHG concentration was 25 mg/mL,the scavenging ability of CHG to ABTS free radicals reached 96.357 2%.Conclusions  CHG has anti-fatigue effect,and its mechanism may be related to anti-oxidation effect.
       在现代快节奏的生活中,不健康的饮食、过量的运动、缺乏休息或体力活动的生活方式,使越来越多的人遭受长时间的疲劳困扰,故消除疲劳并保持旺盛的精力对人体健康显得更有意义[1]中医有食补和药补的传统经验,用于提高正气抗疲劳。中医古方及现代药理学研究[2-6]示:黄芪[Astragalus membranaceus(Fisch.)Bunge]、人参(Panax ginseng C. A. Mey.)、灵芝(Ganoderma lucidum(Curtis)P. Karst.)、枸杞(Lycium chinense Miller)、红景天(Rhodiola rosea L.)和刺五加[Eleutherococcus senticosus(Rupr.&Maxim.)Maxim.]均具有补益正气抗疲劳的作用。但笔者未见关于这6味中药制成复方黄芪颗粒(compound Huangqi granules,CHG)抗疲劳作用的相关报道。本研究通过力竭游泳时间和转棒耐力时间观察CHG对BALB/C小鼠抗疲劳能力的影响,检测小鼠体内血清中血尿素氮(blood urea nitrogen,BUN)、乳酸脱氢酶(lactic dehydrogenase,LDH)、肝糖原、肌糖原、丙二醛(malonaldehyde,MDA)水平及超氧化物歧化酶(superoxide dismutase,SOD)活性,测定CHG体外抗氧化的能力。旨在探讨复方黄芪颗粒对小鼠抗疲劳的作用效果,并考察其抗疲劳的潜在作用机制。

1  材料与方法

1.1 实验动物

       本研究经深圳市众循精准医学研究院实验动物伦理委员会审核通过后开展试验,动物伦理批件:202407310015。48只雄性BALB/C小鼠,3~5周,体质量为18~30 g(广州药康生物科技限公司,实验动物生产许可证号:SYXK(粤)2020-0054),所有小鼠均在Specific Pathogen Free(SPF)生物洁净控制条件下(温度20 ~ 25 ℃,相对湿度45% ~ 60%,明暗循环12∶12 h)饲养,并允许自由获取水和食物,每天更换垫料,保持笼内干燥,实验前适应性饲养7 d,然后进行后续实验。

1.2 主要药物和试剂

       黄芪、人参、灵芝、枸杞、红景天和刺五加6味中药材(华润三九现代中药制药有限公司,批号:20230508、20230612、20230604、20230615、20230718、20230712);小鼠LDH、肝糖原、肌糖原检测试剂盒(上海酶联生物科技有限公司,批号:ML002267、YJ024579、YJ024592);小鼠BUN试剂盒(江苏酶免实业有限公司,批号:MM-0692M2);MDA检测试剂盒、SOD检测试剂盒、1,1-二苯基-2-三硝基苯肼(1,1-Diphenyl-2-picrylhydrazyl,DPPH)自由基和2,2-联氮-二(3-乙基-苯并噻唑-6-磺酸)二铵盐(2,2’-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid,ABTS)自由基清除能力检测试剂盒(北京索莱宝科技有限公司,批号:BC0020、BC0170、BC4755、BC4775);铅丝(广州锂阁科技有限公司,批号:LG43-168-4)。

1.3 主要仪器

       全波长酶标仪(Multiskan GO 1510,Thermo Fisher Scientific公司);超纯水机(PURELAB Chorus1型,法国威立雅公司);小鼠转棒式疲劳仪(YLS-4D型,济南益延科技发展有限公司)。

1.4 方法

       1.4.1  复方黄芪颗粒   复方黄芪颗粒由黄芪20 g、人参9 g、灵芝10 g、枸杞10 g、红景天6 g和刺五加15 g共6味中药材组成,采用传统水煎法提取、过滤、浓缩至清膏含生药量为5.0 g/g,加入淀粉、糖分、糊精水等常见药用辅料,利用湿法制粒经原料准备、混合、制粒、干燥、筛分等步骤制成复方黄芪颗粒。
       1.4.2  动物分组及给药方法   取6~8周健康雄性BALB/C小鼠共计48只,随机分为空白对照组、低剂量组、中剂量组、高剂量组,每组为12只。复方黄芪颗粒20 g,加水适量,定容至70 mL,充分震荡摇匀。灌胃给药体积约0.8 mL,试验组给药量参考《中国药典》2020年修订版,按成人每日服用生药量换算,折算为小鼠所需剂量分别为9.1、18.2和27.3 mg/kg,空白对照组给等体积生理盐水,连续给药30 d。
       1.4.3  小鼠转棒耐力时间的测定    每组小鼠12只,给药3周后,进行一周适应性训练,每次约30 min。试验中剔除跳跃、团身抱轴、不善攀爬的小鼠。第28 d,每组选取6只作为正式试验动物。将小鼠分别置于不停转动的转棒上,启动转速为5 r/min,最终转速为30 r/min,加速时间为50 s,按旋转相反方向运动,小鼠逐渐进入疲劳状态至最后从转棒上跌落,分别记录各只小鼠转棒耐力时间。
       1.4.4  小鼠力竭游泳时间的测定    给药第30 d为末次给药,灌胃30 min后,随机选取6只,置于游泳箱中游泳,水深约为40 cm,水温保持约为(25±5) ℃,尾部固定相对体质量约5 %的铅块。力竭游泳时间以小鼠游泳至头部完全淹没到水中10 s不再浮起为准,及时记录各组小鼠力竭游泳时间。
       1.4.5  小鼠血清活性因子测定    按照前述小鼠力竭游泳时间的测定方法,给药第30 d为末次给药,灌胃30 min后,取每组剩余6只小鼠,无负重游泳90 min,间歇1 h,眼球取血,置于离心管,3 000 r/min离心10 min,取血清。严格按照试剂盒说明书操作,分别测定血清中BUN、LDH、SOD及MDA的含量。
       1.4.6  小鼠肌糖原与肝糖原水平的测定    将前述经眼球取血后的小鼠,乙醚麻醉,脱臼致死后,分别取肝脏和大腿肌肉组织。置于生理盐水中冷藏。试验操作前,剔除多余水分,严格按照试剂盒说明书操作,分别测定肝糖原和肌糖原水平。
        1.4.7  DPPH自由基清除能力的测定    取复方黄芪颗粒分别用提取液配制成2.500 0、5.000 0、6.250 0、12.500 0、25.000 0、50.000 0、100.000 0 mg/mL质量浓度的溶液,维生素C分别用提取液配制成0.031 3、0.062 5、0.125 0、0.250 0、0.300 0、1.000 0 mg/mL质量浓度的溶液,严格按照检测试剂盒说明书操作,调节波长至515 nm,全波长酶标仪测定复方黄芪颗粒的DPPH自由基清除能力。DPPH自由基清除率(D%)的计算按公式(1)和(2)计算:
       1)阳性对照的自由基清除率计算公式:DPPH自由基清除率Dvc%=[(A空白-A阳性对照)÷A空白]×100% (公式1)
       2)样本的自由基清除率计算公式:DPPH自由基清除率D%=[[A空白-(A测定-A对照)]÷A空白]×100% (公式2)
       1.4.8  ABTS自由基清除能力的测定    取复方黄芪颗粒分别用提取液配制成0.625 0、1.250 0、2.500 0、5.000 0、6.250 0、12.500 0、25.000 0、50.000 0 mg/mL质量浓度的溶液,维生素C分别用提取液配制成0.004 5、0.008 9、0.017 9、0.035 7、0.071 4、0.178 6 mg/mL质量浓度的溶液,严格按照检测试剂盒说明书操作,调节波长至405 nm,全波长酶标仪测定复方黄芪颗粒的ABTS自由基清除能力。ABTS自由基清除率(D%)的计算按公式(3)和(4)计算:
       1)阳性对照的自由基清除率计算公式:ABTS自由基清除率Dvc% =[(A空白-A阳性对照)÷A空白]×100%  (公式3)
       2)样本的自由基清除率计算公式:ABTS自由基清除率:D% =[A空白-(A测定-A对照)]÷A空白×100%  (公式4)

1.5 统计学分析

       采用SPSS 26.0进行统计学分析,记录各组小鼠体质量、转棒耐力时间、力竭游泳时间、BUN、LDH、肝糖原、肌糖原、SOD、MDA水平,均以表示,采用方差分析,P<0.05 表示差异有统计学意义。

2  结 果

2.1 对各组小鼠体质量的影响

       试验期间连续35 d测量小鼠体质量,见表1。第4周与空白对照组相比,低剂量组和中剂量组体质量略有增加,高剂量组体质量略有减少。经统计学分析高、中、低3个剂量组小鼠的初始体质量和最终体质量差异均无统计学意义(P>0.05),说明复方黄芪颗粒对小鼠体质量没有明显影响。

1   复方黄芪颗粒对小鼠体质量的影响    (img1n=12)

组别

小鼠体质量的影响/g

试验前1

1

2

3

4

空白组

21.38±0.85

21.72±0.84

23.23±1.35

24.19±1.38

26.45±1.64

低剂量组

21.63±0.82

22.37±0.86

24.49±0.98

25.32±1.22

27.21±1.52

中剂量组

21.41±0.54

21.64±0.49

24.44±0.41

25.36±0.48

27.37±0.34

高剂量组

21.71±0.62

21.40±0.67

23.45±0.96

24.17±0.91

26.02±1.47

                                                                                                           注:与空白组比较,P>0.05

 

 


2.2 对各组小鼠转棒耐力时间的影响

       高、中、低3个剂量的CHG组小鼠转棒时间延长,与空白对照组相比差异有统计学意义,并且转棒耐力时间较空白对照组增加(P<0.01)。见表2。

2   复方黄芪颗粒对小鼠转棒耐力时间及负重游泳时间的影响    (img1n=6)

组别

/g/kg

转棒耐力时/s

力竭游泳时/s

空白组

220.50±15.76

517.17±10.39

低剂量组

9.1

283.83±9.93**

551.33±8.70

中剂量组

18.2

748.33±5.15**

693.00±15.30**

高剂量组

27.3

1 554.50±3.66**

795.67±18.15**

              注:与空白组比较,* P<0.05** P<0.01等体积生理盐水

 

        


2.3 对各组小鼠力竭游泳时间的影响

       高、中2个剂量的CHG组小鼠力竭游泳时间延长,与空白对照组相比差异有统计学意义,并且转棒耐力时间较空白对照组增加(P<0.01)。低剂量组力竭游泳时间略有增加,但是时间增加不明显,与空白对照组相比差异无统计学意义(P0.05)。见表2。

2.4 对各组小鼠血清BUN和LDH水平的影响

       随着给药浓度的增加,BUN浓度逐步减少。经统计学分析,与空白对照组相比,低剂量组和中剂量组小鼠血清BUN浓度略有降低,但差异无统计学意义(P>0.05);高剂量组BUN水平降低明显(P<0.01);与空白对照组相比,高、中、低3个剂量的CHG 组小鼠血清LDH水平降低,与空白对照组相比差异有统计学意义(P<0.01)。见表3。

3  复方黄芪颗粒对小BUNLDH、肝糖原、肌糖原SODMDA含量的影响  (img1)

组别

BUN/μmol/L

LDH/ng/mL

肝糖/ng/mL

肌糖/ng/mL

SOD/U/mL

MDA/μmol/L

空白组

137.28±5.59

19.39±4.01

1 287.38±8.80

1 621.05±21.90

76.31±2.04

38.17±1.66

低剂量组

137.21±7.33

17.73±7.41**

1 558.60±1.48**

1 911.39±12.00

93.58±25.78

35.35±2.62**

中剂量组

131.54±2.43

16.71±2.75**

1 710.47±5.98**

2 031.98±6.17*

95.30±19.04

32.31±1.95**

高剂量组

120.81±4.09**

16.15±3.47**

2 204.83±3.59**

2 076.40±14.50*

134.15±3.14**

21.39±3.61**

                                                                              注:与空白组比较,* P<0.05** P<0.01

 

 


2.5 各组小鼠肝糖原和肌糖原水平

       肝糖原水平与空白对照组相比,高、中、低3个剂量的 CHG组小鼠肝糖原水平升高,差异有统计学意义(P<0.01)。肌糖原水平与空白对照组相比,高、中、低3个剂量的 CHG组小鼠肌糖原水平升高,经统计学分析只有高剂量组和中剂量组差异有统计学意义(P<0.05),低剂量组差异无统计学意义(P>0.05)。见表3。

2.6 对各组小鼠血清SOD活性和MDA水平的影响

       与空白对照组相比,高剂量的 CHG组小鼠SOD活性升高,中剂量组和低剂量组小鼠血清SOD活性略有提高,经统计学分析只有高剂量组差异有统计学意义(P<0.01),低剂量组和中剂量组差异无统计学意义(P>0.05)。与空白对照组相比,高、中、低3个剂量的 CHG组小鼠MDA水平明显降低,经统计学分析3个剂量组差异均有统计学意义(P<0.01)。见表3。

2.7 DPPH自由基清除能力的测定

       随着维生素C和复方黄芪颗粒质量浓度的增加,DPPH自由基清除能力也逐步增加。当CHG质量浓度为2.500 0 mg/mL时,CHG对DPPH自由基清除能力只有2.033 3%。当CHG质量浓度为100.000 0 mg/mL时,CHG对DPPH自由基清除能力可达85.030 3%,与1.000 0 mg/mL质量浓度维生素C的氧化抑制率只相差约6.836 7%。见图1。
20250509112305_3583_thumb.jpg

2.8 ABTS自由基清除能力的测定

       随着维生素C和复方黄芪颗粒浓度的增加,ABTS自由基清除能力也逐步增加。当CHG质量浓度为25.000 0 mg/mL时,CHG对ABTS自由基清除能力可达96.3572%,当质量浓度达到50.000 0 mg/mL时,CHG对ABTS自由基清除能力可达98.300 0%。说明25.000 0 mg/mL时,CHG对ABTS自由基清除能力基本达到峰值。质量浓度为0.035 7 mg/mL维生素C与质量浓度为12.500 0 mg/mL的CHG的氧化抑制率基本相当。见图2。
20250509112337_2841_thumb.jpg

3  讨 论

       《金匮要略》始载“虚劳”之病名,分阳虚、阴虚、阴阳两虚三类[7-8]。明·汪绮石《理虚元鉴》曰:治虚有三本,肺、脾、肾是也[9]张景岳提出:善补阳者,必于阴中求阳,善补阴者,必于阳中求阴。方中黄芪味甘,性微温,归肺、脾经,补脾阳以固肺阴,为君药[10]。人参性味甘温,归脾、肺、心、肾经,一方面协助黄芪补脾肺之气、增强补益之功效,另一方面连同甘平之药灵芝、枸杞子,益心肺之气,养肝肾之阴,达到阴阳互补,阴阳双补的功效,共同为臣药。佐以红景天、刺五加通利血脉,助力气血运行,补五脏全身之气,平衡五脏全身阴阳,最终达到补益气血阴阳的目的。
       目前,用于评价抗疲劳效果的主要指标:(1)抗氧化指标:MDA、SOD、谷胱甘肽过氧化物酶、过氧化氢酶等[11-12];(2)有害代谢物:LDH和BUN等[13-14];(3)炎症:肿瘤坏死因子、IL-1b和IL-6等[15]。疲劳会影响生物体的代谢,从而导致代谢产物的积累。由于能量需求增加,生物体中的蛋白质和氨基酸分解并释放代谢物。疲劳产生与机体中的MDA、SOD、BUN、LDH、肌糖原和肝糖原等有关物质的含量密切相[16-17]。人体运动时优先消耗肌糖原,随着其消耗,机体将被迫开始肝糖原的消耗来维持血糖平衡,故人体疲劳程度的指标可以用肌糖原和肝糖原来表达。运动期间产生乳酸可降低血液和肌肉组织中的pH值而引起疲劳,这也是疲劳症状的主要触发因素[18-19]。人体剧烈运动时,能量会大量消耗,此时细胞呼吸主要为无氧呼吸,会使LDH含量增加,使体内各种酶活力受影响,导致肌肉功能下降,产生疲劳感。同时,运动剧烈时,蛋白质会首先水解产生氨基酸,再代谢产生氨,氨再通过肝尿素循环合成尿素,最终形成BUN,其含量与机体的运动耐量呈负相关。BUN是蛋白质和氨基酸降解的产物之一,可降低耐力并引起疲[20]。大部分多糖、黄酮以及皂苷成分都具有减少代谢产物积累的优势,如三七、人参中人参皂苷可通过降低血清中BUN和LDH水平,提高肝糖原含量,以此增加机体抗疲劳作用[21-22],黄芪中的黄芪甲苷和黄芪多糖等成分均具有一定的抗疲劳作用[23],灵芝孢子油软胶囊对小鼠具有抗疲劳的作用,可有效提高负重游泳时间和肝糖原水平,降低LDH的水平[24]。DPPH其醇溶液为紫色,含有单电子,遇到自由基清除剂会出现褪色,在515 nm处吸收较强[25]。抗氧化成分能与ABTS自由基发生反应而使反应体系褪色,在405 nm处吸光度明显下降,通过吸光度下降的程度即可反映样本清除ABTS自由基的能力[26]
       本研究主要探讨黄芪、人参、灵芝、枸杞、红景天和刺五加混合提取物制成颗粒对小鼠前后体质量、转棒耐力时间、力竭游泳时间及其体内的BUN、LDH、肝糖原、肌糖原水平、SOD活性、MDA水平、DPPH和ABTS自由基清除能力的测定,探究CHG颗粒对小鼠抗疲劳的作用及其作用机制。结果证明复方黄芪颗粒在连续30 d给药后对各组小鼠体质量均无影响,通过转棒耐力时间和游泳力竭时间评估了复方黄芪颗粒对小鼠抗疲劳活性的影响,结果表明复方黄芪颗粒可剂量依赖性地延迟小鼠的转棒耐力时间和游泳力竭时间,而所有中剂量和高剂量组相比空白对照组差异均有统计学意义。因此,可初步确定复方黄芪颗粒具有抗疲劳作用。而后对高、中、低三个剂量组给药后的小鼠生化指标进行测定,结果显示对维持肌糖原、肝糖原、SOD水平具有积极作用,同时对减少BUN、LDH和MDA的积累具有积极作用。体外抗氧化试验表明CHG以剂量依赖性方式清除ABTS和DPPH自由基。另外,复方黄芪颗粒经过30 d给药后发现,未见明显不良反应,安全性较高。
1、DUKES%E2%80%83J%E2%80%83C%EF%BC%8CCHAKAN%E2%80%83M%EF%BC%8CMILLS%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AApproach%E2%80%83to%E2%80%83fatigue%EF%BC%9ABest%E2%80%83Practice%EF%BC%BBJ%EF%BC%BD%EF%BC%8EMed%E2%80%83Clin%E2%80%83%0ANorth%E2%80%83Am%EF%BC%8C2021%EF%BC%8C105%EF%BC%881%EF%BC%89%EF%BC%9A137-148%EF%BC%8EDUKES%E2%80%83J%E2%80%83C%EF%BC%8CCHAKAN%E2%80%83M%EF%BC%8CMILLS%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AApproach%E2%80%83to%E2%80%83fatigue%EF%BC%9ABest%E2%80%83Practice%EF%BC%BBJ%EF%BC%BD%EF%BC%8EMed%E2%80%83Clin%E2%80%83%0ANorth%E2%80%83Am%EF%BC%8C2021%EF%BC%8C105%EF%BC%881%EF%BC%89%EF%BC%9A137-148%EF%BC%8E
2、LI%E2%80%83C%E2%80%83X%EF%BC%8CLIU%E2%80%83Y%EF%BC%8CZHANG%E2%80%83Y%E2%80%83Z%EF%BC%8Cet%E2%80%83al%EF%BC%8EAstragalus%E2%80%83%0Apolysaccharide%EF%BC%9AA%E2%80%83%20review%E2%80%83%20of%E2%80%83its%E2%80%83immunomodulatory%E2%80%83%0Aeffect%EF%BC%BBJ%EF%BC%BD%EF%BC%8EArch%E2%80%83Pharm%E2%80%83Res%EF%BC%8C2022%EF%BC%8C45%EF%BC%886%EF%BC%89%EF%BC%9A%0A367-389%EF%BC%8ELI%E2%80%83C%E2%80%83X%EF%BC%8CLIU%E2%80%83Y%EF%BC%8CZHANG%E2%80%83Y%E2%80%83Z%EF%BC%8Cet%E2%80%83al%EF%BC%8EAstragalus%E2%80%83%0Apolysaccharide%EF%BC%9AA%E2%80%83%20review%E2%80%83%20of%E2%80%83its%E2%80%83immunomodulatory%E2%80%83%0Aeffect%EF%BC%BBJ%EF%BC%BD%EF%BC%8EArch%E2%80%83Pharm%E2%80%83Res%EF%BC%8C2022%EF%BC%8C45%EF%BC%886%EF%BC%89%EF%BC%9A%0A367-389%EF%BC%8E
3、LU%E2%80%83G%EF%BC%8CLIU%E2%80%83Z%EF%BC%8CWANG%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8ERecent%E2%80%83aAdvances%E2%80%83%0Ain%E2%80%83Panax%E2%80%83ginseng%E2%80%83C%EF%BC%8EA%EF%BC%8EMeyer%E2%80%83as%E2%80%83a%E2%80%83herb%E2%80%83for%E2%80%83anti%02fatigue%EF%BC%9AAn%E2%80%83effects%E2%80%83and%E2%80%83mechanisms%E2%80%83review%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0AFoods%EF%BC%8C2021%EF%BC%8C10%EF%BC%885%EF%BC%89%EF%BC%9A1030%EF%BC%8ELU%E2%80%83G%EF%BC%8CLIU%E2%80%83Z%EF%BC%8CWANG%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8ERecent%E2%80%83aAdvances%E2%80%83%0Ain%E2%80%83Panax%E2%80%83ginseng%E2%80%83C%EF%BC%8EA%EF%BC%8EMeyer%E2%80%83as%E2%80%83a%E2%80%83herb%E2%80%83for%E2%80%83anti%02fatigue%EF%BC%9AAn%E2%80%83effects%E2%80%83and%E2%80%83mechanisms%E2%80%83review%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0AFoods%EF%BC%8C2021%EF%BC%8C10%EF%BC%885%EF%BC%89%EF%BC%9A1030%EF%BC%8E
4、SU%E2%80%83L%EF%BC%8CLI%E2%80%83D%EF%BC%8CSU%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8EPolysaccharides%E2%80%83%20of%E2%80%83%0Asporoderm-broken%E2%80%83%20spore%E2%80%83%20of%E2%80%83%20ganoderma%E2%80%83%20lucidum%E2%80%83%0Amodulate%E2%80%83adaptive%E2%80%83immune%E2%80%83function%E2%80%83via%E2%80%83gut%E2%80%83microbiota%E2%80%83%0Aregulation%EF%BC%BBJ%EF%BC%BD%EF%BC%8EEvid%E2%80%83Based%E2%80%83Complement%E2%80%83Alternat%E2%80%83%0AMed%EF%BC%8C2021%EF%BC%8C%EF%BC%882021%EF%BC%89%EF%BC%9A8842062%EF%BC%8ESU%E2%80%83L%EF%BC%8CLI%E2%80%83D%EF%BC%8CSU%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8EPolysaccharides%E2%80%83%20of%E2%80%83%0Asporoderm-broken%E2%80%83%20spore%E2%80%83%20of%E2%80%83%20ganoderma%E2%80%83%20lucidum%E2%80%83%0Amodulate%E2%80%83adaptive%E2%80%83immune%E2%80%83function%E2%80%83via%E2%80%83gut%E2%80%83microbiota%E2%80%83%0Aregulation%EF%BC%BBJ%EF%BC%BD%EF%BC%8EEvid%E2%80%83Based%E2%80%83Complement%E2%80%83Alternat%E2%80%83%0AMed%EF%BC%8C2021%EF%BC%8C%EF%BC%882021%EF%BC%89%EF%BC%9A8842062%EF%BC%8E
5、XIAO%E2%80%83Z%EF%BC%8CDENG%E2%80%83Q%EF%BC%8CZHOU%E2%80%83W%EF%BC%8Cet%E2%80%83al%EF%BC%8EImmune%E2%80%83%0Aactivities%E2%80%83%20of%E2%80%83%20polysaccharides%E2%80%83isolated%E2%80%83from%E2%80%83%20Lycium%E2%80%83%0Abarbarum%E2%80%83L%EF%BC%8EWhat%E2%80%83do%E2%80%83we%E2%80%83know%E2%80%83so%E2%80%83far%EF%BC%9F%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0APharmacol%E2%80%83Ther%EF%BC%8C2022%EF%BC%88229%EF%BC%89%EF%BC%9A107921%EF%BC%8EXIAO%E2%80%83Z%EF%BC%8CDENG%E2%80%83Q%EF%BC%8CZHOU%E2%80%83W%EF%BC%8Cet%E2%80%83al%EF%BC%8EImmune%E2%80%83%0Aactivities%E2%80%83%20of%E2%80%83%20polysaccharides%E2%80%83isolated%E2%80%83from%E2%80%83%20Lycium%E2%80%83%0Abarbarum%E2%80%83L%EF%BC%8EWhat%E2%80%83do%E2%80%83we%E2%80%83know%E2%80%83so%E2%80%83far%EF%BC%9F%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0APharmacol%E2%80%83Ther%EF%BC%8C2022%EF%BC%88229%EF%BC%89%EF%BC%9A107921%EF%BC%8E
6、KIM%E2%80%83C%EF%BC%8CBAE%E2%80%83H%E2%80%83M%EF%BC%8CBAIK%E2%80%83I%EF%BC%8EPotential%E2%80%83%20antiaging%E2%80%83%0Aand%E2%80%83%20hepatop%20rotective%E2%80%83%20effects%E2%80%83%20of%E2%80%83%20Acanthopanax%E2%80%83senticosus%E2%80%83extracts%E2%80%83in%E2%80%83adult%E2%80%83rat%E2%80%83models%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0ARejuvenation%E2%80%83Res%EF%BC%8C2023%EF%BC%8C26%EF%BC%882%EF%BC%89%EF%BC%9A51-56%EF%BC%8EKIM%E2%80%83C%EF%BC%8CBAE%E2%80%83H%E2%80%83M%EF%BC%8CBAIK%E2%80%83I%EF%BC%8EPotential%E2%80%83%20antiaging%E2%80%83%0Aand%E2%80%83%20hepatop%20rotective%E2%80%83%20effects%E2%80%83%20of%E2%80%83%20Acanthopanax%E2%80%83senticosus%E2%80%83extracts%E2%80%83in%E2%80%83adult%E2%80%83rat%E2%80%83models%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0ARejuvenation%E2%80%83Res%EF%BC%8C2023%EF%BC%8C26%EF%BC%882%EF%BC%89%EF%BC%9A51-56%EF%BC%8E
7、王桂彬,庞博.《金匮要略》血痹虚劳病篇探赜[J].中国中医基础医学杂志,2023,29(5):709-711.王桂彬,庞博.《金匮要略》血痹虚劳病篇探赜[J].中国中医基础医学杂志,2023,29(5):709-711.
8、王东军,田之魁,焦锟,等.《金匮要略·血痹虚劳病脉证并治》虚劳病精气神调治原则与方法[J].天津中医药,2022,39(4):466-469.王东军,田之魁,焦锟,等.《金匮要略·血痹虚劳病脉证并治》虚劳病精气神调治原则与方法[J].天津中医药,2022,39(4):466-469.
9、%E2%80%83%20SONG%E2%80%83Y%E2%80%83Y%EF%BC%8CZHANG%E2%80%83X%E2%80%83Y%EF%BC%8CTIAN%E2%80%83H%EF%BC%8ECharacteristics%E2%80%83%0Aof%E2%80%83%20differentiation%E2%80%83%20and%E2%80%83treatment%E2%80%83%20of%E2%80%83%20deficiency%E2%80%83%20and%E2%80%83%0Aexhaustion%E2%80%83in%E2%80%83Lixu%E2%80%83Yuan%E2%80%83Jian%EF%BC%BBJ%EF%BC%BD%EF%BC%8EHenan%E2%80%83%20J%E2%80%83%20Trad%E2%80%83%0AChin%E2%80%83Med%EF%BC%8C2023%EF%BC%8C43%EF%BC%888%EF%BC%89%EF%BC%9A1171-1174%EF%BC%8E%E2%80%83%20SONG%E2%80%83Y%E2%80%83Y%EF%BC%8CZHANG%E2%80%83X%E2%80%83Y%EF%BC%8CTIAN%E2%80%83H%EF%BC%8ECharacteristics%E2%80%83%0Aof%E2%80%83%20differentiation%E2%80%83%20and%E2%80%83treatment%E2%80%83%20of%E2%80%83%20deficiency%E2%80%83%20and%E2%80%83%0Aexhaustion%E2%80%83in%E2%80%83Lixu%E2%80%83Yuan%E2%80%83Jian%EF%BC%BBJ%EF%BC%BD%EF%BC%8EHenan%E2%80%83%20J%E2%80%83%20Trad%E2%80%83%0AChin%E2%80%83Med%EF%BC%8C2023%EF%BC%8C43%EF%BC%888%EF%BC%89%EF%BC%9A1171-1174%EF%BC%8E
10、ABD%E2%80%83ELRAHIM%E2%80%83ABD%E2%80%83ELKADER%E2%80%83H%E2%80%83T%EF%BC%8CESSAWY%E2%80%83%0AA%E2%80%83E%EF%BC%8CAL-SHAMI%E2%80%83A%E2%80%83S%EF%BC%8EAstragalus%E2%80%83species%EF%BC%9A%0APhytochemistry%EF%BC%8Cbiological%E2%80%83%20actions%E2%80%83%20and%E2%80%83%20molecular%E2%80%83%0Amechanisms%E2%80%83underlying%E2%80%83their%E2%80%83potential%E2%80%83neuroprotective%E2%80%83%0Aeffects%E2%80%83on%E2%80%83neurological%E2%80%83diseases%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPhytochemistry%EF%BC%8C%0A2022%EF%BC%88202%EF%BC%89%EF%BC%9A113293%EF%BC%8EABD%E2%80%83ELRAHIM%E2%80%83ABD%E2%80%83ELKADER%E2%80%83H%E2%80%83T%EF%BC%8CESSAWY%E2%80%83%0AA%E2%80%83E%EF%BC%8CAL-SHAMI%E2%80%83A%E2%80%83S%EF%BC%8EAstragalus%E2%80%83species%EF%BC%9A%0APhytochemistry%EF%BC%8Cbiological%E2%80%83%20actions%E2%80%83%20and%E2%80%83%20molecular%E2%80%83%0Amechanisms%E2%80%83underlying%E2%80%83their%E2%80%83potential%E2%80%83neuroprotective%E2%80%83%0Aeffects%E2%80%83on%E2%80%83neurological%E2%80%83diseases%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPhytochemistry%EF%BC%8C%0A2022%EF%BC%88202%EF%BC%89%EF%BC%9A113293%EF%BC%8E
11、CHEN%E2%80%83J%E2%80%83B%EF%BC%8CLI%E2%80%83M%E2%80%83J%EF%BC%8CCHEN%E2%80%83L%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8ECorrigendum%E2%80%83%0Ato%E2%80%83%E2%80%9CEffects%E2%80%83%20of%E2%80%83Raphani%E2%80%83%20Semen%E2%80%83%20on%E2%80%83%20anti-fatigue%E2%80%83%20and%E2%80%83%0Apharmacokinetics%E2%80%83of%E2%80%83Panax%E2%80%83ginseng%E2%80%9C%E2%80%83Chinese%E2%80%83Herbal%E2%80%83%0AMedicines%E2%80%8311%E2%80%832019%E2%80%83308-313%EF%BC%BBJ%EF%BC%BD%EF%BC%8EChin%E2%80%83Herb%E2%80%83Med%EF%BC%8C%0A2021%EF%BC%8C13%EF%BC%882%EF%BC%89%EF%BC%9A290%EF%BC%8ECHEN%E2%80%83J%E2%80%83B%EF%BC%8CLI%E2%80%83M%E2%80%83J%EF%BC%8CCHEN%E2%80%83L%E2%80%83X%EF%BC%8Cet%E2%80%83al%EF%BC%8ECorrigendum%E2%80%83%0Ato%E2%80%83%E2%80%9CEffects%E2%80%83%20of%E2%80%83Raphani%E2%80%83%20Semen%E2%80%83%20on%E2%80%83%20anti-fatigue%E2%80%83%20and%E2%80%83%0Apharmacokinetics%E2%80%83of%E2%80%83Panax%E2%80%83ginseng%E2%80%9C%E2%80%83Chinese%E2%80%83Herbal%E2%80%83%0AMedicines%E2%80%8311%E2%80%832019%E2%80%83308-313%EF%BC%BBJ%EF%BC%BD%EF%BC%8EChin%E2%80%83Herb%E2%80%83Med%EF%BC%8C%0A2021%EF%BC%8C13%EF%BC%882%EF%BC%89%EF%BC%9A290%EF%BC%8E
12、%E2%80%83%20CHEN%E2%80%83X%EF%BC%8CLIANG%E2%80%83D%EF%BC%8CHUANG%E2%80%83Z%EF%BC%8Cet%E2%80%83al%EF%BC%8EAnti-fatigue%E2%80%83%0Aeffect%E2%80%83of%E2%80%83quercetin%E2%80%83on%E2%80%83enhancing%E2%80%83muscle%E2%80%83function%E2%80%83and%E2%80%83%0Aantioxidant%E2%80%83capacity%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Food%E2%80%83Biochem%EF%BC%8C2021%EF%BC%8C%0A45%EF%BC%8811%EF%BC%89%EF%BC%9Ae13968%EF%BC%8E%E2%80%83%20CHEN%E2%80%83X%EF%BC%8CLIANG%E2%80%83D%EF%BC%8CHUANG%E2%80%83Z%EF%BC%8Cet%E2%80%83al%EF%BC%8EAnti-fatigue%E2%80%83%0Aeffect%E2%80%83of%E2%80%83quercetin%E2%80%83on%E2%80%83enhancing%E2%80%83muscle%E2%80%83function%E2%80%83and%E2%80%83%0Aantioxidant%E2%80%83capacity%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83Food%E2%80%83Biochem%EF%BC%8C2021%EF%BC%8C%0A45%EF%BC%8811%EF%BC%89%EF%BC%9Ae13968%EF%BC%8E
13、JAFERNIK%E2%80%83K%EF%BC%8CEKIERT%E2%80%83H%EF%BC%8CSZOPA%E2%80%83%E2%80%83A%EF%BC%8E%E2%80%83Schisandra%E2%80%83%0Ahenryi-a%E2%80%83rare%E2%80%83species%E2%80%83with%E2%80%83high%E2%80%83medicinal%E2%80%83potential%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EMolecules%EF%BC%8C2023%EF%BC%8C28%EF%BC%8811%EF%BC%89%EF%BC%9A4333%EF%BC%8EJAFERNIK%E2%80%83K%EF%BC%8CEKIERT%E2%80%83H%EF%BC%8CSZOPA%E2%80%83%E2%80%83A%EF%BC%8E%E2%80%83Schisandra%E2%80%83%0Ahenryi-a%E2%80%83rare%E2%80%83species%E2%80%83with%E2%80%83high%E2%80%83medicinal%E2%80%83potential%0A%EF%BC%BBJ%EF%BC%BD%EF%BC%8EMolecules%EF%BC%8C2023%EF%BC%8C28%EF%BC%8811%EF%BC%89%EF%BC%9A4333%EF%BC%8E
14、%E2%80%83GAO%E2%80%83H%20%EF%BC%8C%20ZHANG%E2%80%83W%20%EF%BC%8C%20WANG%E2%80%83B%20%EF%BC%8C%20et%E2%80%83al%20%EF%BC%8E%0APurification%EF%BC%8Ccharacterization%E2%80%83and%E2%80%83anti-fatigue%E2%80%83activity%E2%80%83%0Aof%E2%80%83polysaccharide%E2%80%83fractions%E2%80%83from%E2%80%83okra%EF%BC%88Abelmoschus%E2%80%83%0Aesculentus%EF%BC%88L%EF%BC%8E%EF%BC%89Moench%EF%BC%89%EF%BC%BBJ%EF%BC%BD%EF%BC%8EFood%E2%80%83Funct%EF%BC%8C%0A2018%EF%BC%8C9%EF%BC%882%EF%BC%89%EF%BC%9A1088-1101%EF%BC%8E%E2%80%83GAO%E2%80%83H%20%EF%BC%8C%20ZHANG%E2%80%83W%20%EF%BC%8C%20WANG%E2%80%83B%20%EF%BC%8C%20et%E2%80%83al%20%EF%BC%8E%0APurification%EF%BC%8Ccharacterization%E2%80%83and%E2%80%83anti-fatigue%E2%80%83activity%E2%80%83%0Aof%E2%80%83polysaccharide%E2%80%83fractions%E2%80%83from%E2%80%83okra%EF%BC%88Abelmoschus%E2%80%83%0Aesculentus%EF%BC%88L%EF%BC%8E%EF%BC%89Moench%EF%BC%89%EF%BC%BBJ%EF%BC%BD%EF%BC%8EFood%E2%80%83Funct%EF%BC%8C%0A2018%EF%BC%8C9%EF%BC%882%EF%BC%89%EF%BC%9A1088-1101%EF%BC%8E
15、%E2%80%83%20HERLOFSON%E2%80%83K%EF%BC%8CHEIJNEN%E2%80%83C%E2%80%83J%EF%BC%8CLANGE%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AInflammation%E2%80%83and%E2%80%83fatigue%E2%80%83in%E2%80%83early%EF%BC%8Cunt%20reated%E2%80%83%0AParkinson%E2%80%99s%E2%80%83Disease%EF%BC%BBJ%EF%BC%BD%EF%BC%8EActa%E2%80%83Neurol%E2%80%83Scand%EF%BC%8C%0A2018%EF%BC%8C138%EF%BC%885%EF%BC%89%EF%BC%9A394-399%EF%BC%8E%E2%80%83%20HERLOFSON%E2%80%83K%EF%BC%8CHEIJNEN%E2%80%83C%E2%80%83J%EF%BC%8CLANGE%E2%80%83J%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AInflammation%E2%80%83and%E2%80%83fatigue%E2%80%83in%E2%80%83early%EF%BC%8Cunt%20reated%E2%80%83%0AParkinson%E2%80%99s%E2%80%83Disease%EF%BC%BBJ%EF%BC%BD%EF%BC%8EActa%E2%80%83Neurol%E2%80%83Scand%EF%BC%8C%0A2018%EF%BC%8C138%EF%BC%885%EF%BC%89%EF%BC%9A394-399%EF%BC%8E
16、%E2%80%83%20LI%E2%80%83D%EF%BC%8CREN%E2%80%83J%E2%80%83W%EF%BC%8CZHANG%E2%80%83T%EF%BC%8Cet%E2%80%83al%EF%BC%8EAnti-fatigue%E2%80%83%0Aeffects%E2%80%83of%E2%80%83%20small-molecule%E2%80%83oligopeptides%E2%80%83isolated%E2%80%83from%E2%80%83Panax%E2%80%83quinquefolium%E2%80%83L%EF%BC%8Ein%E2%80%83mice%EF%BC%BBJ%EF%BC%BD%EF%BC%8EFood%E2%80%83Funct%EF%BC%8C%0A2018%EF%BC%8C9%EF%BC%888%EF%BC%89%EF%BC%9A4266-4273%EF%BC%8E%E2%80%83%20LI%E2%80%83D%EF%BC%8CREN%E2%80%83J%E2%80%83W%EF%BC%8CZHANG%E2%80%83T%EF%BC%8Cet%E2%80%83al%EF%BC%8EAnti-fatigue%E2%80%83%0Aeffects%E2%80%83of%E2%80%83%20small-molecule%E2%80%83oligopeptides%E2%80%83isolated%E2%80%83from%E2%80%83Panax%E2%80%83quinquefolium%E2%80%83L%EF%BC%8Ein%E2%80%83mice%EF%BC%BBJ%EF%BC%BD%EF%BC%8EFood%E2%80%83Funct%EF%BC%8C%0A2018%EF%BC%8C9%EF%BC%888%EF%BC%89%EF%BC%9A4266-4273%EF%BC%8E
17、SADDHE%E2%80%83A%E2%80%83A%EF%BC%8CMANUKA%E2%80%83R%EF%BC%8CPENNA%E2%80%83S%EF%BC%8EPlant%E2%80%83%0Asugars%EF%BC%9AHomeostasis%E2%80%83and%E2%80%83transport%E2%80%83under%E2%80%83abiotic%E2%80%83stress%E2%80%83%0Ain%E2%80%83plants%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPhysiol%E2%80%83Plant%EF%BC%8C2021%EF%BC%8C171%EF%BC%884%EF%BC%89%EF%BC%9A%0A739-755%EF%BC%8ESADDHE%E2%80%83A%E2%80%83A%EF%BC%8CMANUKA%E2%80%83R%EF%BC%8CPENNA%E2%80%83S%EF%BC%8EPlant%E2%80%83%0Asugars%EF%BC%9AHomeostasis%E2%80%83and%E2%80%83transport%E2%80%83under%E2%80%83abiotic%E2%80%83stress%E2%80%83%0Ain%E2%80%83plants%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPhysiol%E2%80%83Plant%EF%BC%8C2021%EF%BC%8C171%EF%BC%884%EF%BC%89%EF%BC%9A%0A739-755%EF%BC%8E
18、%E2%80%83%20MATSUI%E2%80%83T%EF%BC%8EExhaustive%E2%80%83endurance%E2%80%83exercise%E2%80%83activates%E2%80%83%0Abrain%E2%80%83%20glycogen%E2%80%83%20breakdown%E2%80%83%20and%E2%80%83lactate%E2%80%83%20production%E2%80%83%0Amore%E2%80%83than%E2%80%83insulin-induced%E2%80%83hypoglycemia%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAm%E2%80%83%0AJ%E2%80%83Physiol%E2%80%83Regul%E2%80%83Integr%E2%80%83Comp%E2%80%83Physiol%EF%BC%8C2021%EF%BC%8C320%0A%EF%BC%884%EF%BC%89%EF%BC%9AR500-R507%EF%BC%8E%E2%80%83%20MATSUI%E2%80%83T%EF%BC%8EExhaustive%E2%80%83endurance%E2%80%83exercise%E2%80%83activates%E2%80%83%0Abrain%E2%80%83%20glycogen%E2%80%83%20breakdown%E2%80%83%20and%E2%80%83lactate%E2%80%83%20production%E2%80%83%0Amore%E2%80%83than%E2%80%83insulin-induced%E2%80%83hypoglycemia%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAm%E2%80%83%0AJ%E2%80%83Physiol%E2%80%83Regul%E2%80%83Integr%E2%80%83Comp%E2%80%83Physiol%EF%BC%8C2021%EF%BC%8C320%0A%EF%BC%884%EF%BC%89%EF%BC%9AR500-R507%EF%BC%8E
19、MATSUI%E2%80%83T%EF%BC%8CSOYA%E2%80%83M%EF%BC%8CSOYA%E2%80%83H%EF%BC%8EEndurance%E2%80%83%20and%E2%80%83%0Abrain%E2%80%83glycogen%EF%BC%9AA%E2%80%83clue%E2%80%83toward%E2%80%83Understanding%E2%80%83central%E2%80%83%0Afatigue%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAdv%E2%80%83Neurobiol%EF%BC%8C2019%EF%BC%8823%EF%BC%89%EF%BC%9A331-%0A346%EF%BC%8EMATSUI%E2%80%83T%EF%BC%8CSOYA%E2%80%83M%EF%BC%8CSOYA%E2%80%83H%EF%BC%8EEndurance%E2%80%83%20and%E2%80%83%0Abrain%E2%80%83glycogen%EF%BC%9AA%E2%80%83clue%E2%80%83toward%E2%80%83Understanding%E2%80%83central%E2%80%83%0Afatigue%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAdv%E2%80%83Neurobiol%EF%BC%8C2019%EF%BC%8823%EF%BC%89%EF%BC%9A331-%0A346%EF%BC%8E
20、LAMOU%E2%80%83B%EF%BC%8CTAIWE%E2%80%83G%E2%80%83S%EF%BC%8CHAMADOU%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AAntioxidant%E2%80%83and%E2%80%83antifatigue%E2%80%83properties%E2%80%83of%E2%80%83the%E2%80%83aqueous%E2%80%83%0Aextract%E2%80%83of%E2%80%83moringa%E2%80%83oleifera%E2%80%83in%E2%80%83%20rats%E2%80%83subjected%E2%80%83to%E2%80%83forced%E2%80%83%0Aswimming%E2%80%83endurance%E2%80%83test%EF%BC%BBJ%EF%BC%BD%EF%BC%8EOxid%E2%80%83%20Med%E2%80%83%20Cell%E2%80%83%0ALongev%EF%BC%8C2016%EF%BC%882016%EF%BC%89%EF%BC%9A3517824%EF%BC%8ELAMOU%E2%80%83B%EF%BC%8CTAIWE%E2%80%83G%E2%80%83S%EF%BC%8CHAMADOU%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8E%0AAntioxidant%E2%80%83and%E2%80%83antifatigue%E2%80%83properties%E2%80%83of%E2%80%83the%E2%80%83aqueous%E2%80%83%0Aextract%E2%80%83of%E2%80%83moringa%E2%80%83oleifera%E2%80%83in%E2%80%83%20rats%E2%80%83subjected%E2%80%83to%E2%80%83forced%E2%80%83%0Aswimming%E2%80%83endurance%E2%80%83test%EF%BC%BBJ%EF%BC%BD%EF%BC%8EOxid%E2%80%83%20Med%E2%80%83%20Cell%E2%80%83%0ALongev%EF%BC%8C2016%EF%BC%882016%EF%BC%89%EF%BC%9A3517824%EF%BC%8E
21、%E2%80%83%20YOON%E2%80%83S%E2%80%83J%EF%BC%8CKIM%E2%80%83S%E2%80%83K%EF%BC%8CLEE%E2%80%83N%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8EEffect%E2%80%83%20of%E2%80%83%0AKorean%E2%80%83Red%E2%80%83Ginseng%E2%80%83on%E2%80%83metabolic%E2%80%83syndrome%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83%0AGinseng%E2%80%83Res%EF%BC%8C2021%EF%BC%8C45%EF%BC%883%EF%BC%89%EF%BC%9A380-389%EF%BC%8E%E2%80%83%20YOON%E2%80%83S%E2%80%83J%EF%BC%8CKIM%E2%80%83S%E2%80%83K%EF%BC%8CLEE%E2%80%83N%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8EEffect%E2%80%83%20of%E2%80%83%0AKorean%E2%80%83Red%E2%80%83Ginseng%E2%80%83on%E2%80%83metabolic%E2%80%83syndrome%EF%BC%BBJ%EF%BC%BD%EF%BC%8EJ%E2%80%83%0AGinseng%E2%80%83Res%EF%BC%8C2021%EF%BC%8C45%EF%BC%883%EF%BC%89%EF%BC%9A380-389%EF%BC%8E
22、LIU%E2%80%83H%EF%BC%8CLU%E2%80%83X%EF%BC%8CHU%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8EChemical%E2%80%83constituents%E2%80%83%0Aof%E2%80%83Panax%E2%80%83ginseng%E2%80%83and%E2%80%83Panax%E2%80%83notoginseng%E2%80%83explain%E2%80%83why%E2%80%83%0Athey%E2%80%83differ%E2%80%83in%E2%80%83therapeutic%E2%80%83efficacy%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPharmacol%E2%80%83%0ARes%EF%BC%8C2020%EF%BC%88161%EF%BC%89%EF%BC%9A105263%EF%BC%8ELIU%E2%80%83H%EF%BC%8CLU%E2%80%83X%EF%BC%8CHU%E2%80%83Y%EF%BC%8Cet%E2%80%83al%EF%BC%8EChemical%E2%80%83constituents%E2%80%83%0Aof%E2%80%83Panax%E2%80%83ginseng%E2%80%83and%E2%80%83Panax%E2%80%83notoginseng%E2%80%83explain%E2%80%83why%E2%80%83%0Athey%E2%80%83differ%E2%80%83in%E2%80%83therapeutic%E2%80%83efficacy%EF%BC%BBJ%EF%BC%BD%EF%BC%8EPharmacol%E2%80%83%0ARes%EF%BC%8C2020%EF%BC%88161%EF%BC%89%EF%BC%9A105263%EF%BC%8E
23、%E2%80%83%20ZAMAN%E2%80%83Q%EF%BC%8CZHANG%E2%80%83D%EF%BC%8CREDDY%E2%80%83O%E2%80%83S%EF%BC%8Cet%E2%80%83al%EF%BC%8ERoles%E2%80%83%0Aand%E2%80%83%20mechanisms%E2%80%83%20of%E2%80%83%20astragaloside%E2%80%83%20IV%E2%80%83in%E2%80%83%20combating%E2%80%83%0Aneuronal%E2%80%83aging%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAging%E2%80%83Dis%EF%BC%8C2022%EF%BC%8C13%EF%BC%886%EF%BC%89%EF%BC%9A%0A1845-1861%EF%BC%8E%E2%80%83%20ZAMAN%E2%80%83Q%EF%BC%8CZHANG%E2%80%83D%EF%BC%8CREDDY%E2%80%83O%E2%80%83S%EF%BC%8Cet%E2%80%83al%EF%BC%8ERoles%E2%80%83%0Aand%E2%80%83%20mechanisms%E2%80%83%20of%E2%80%83%20astragaloside%E2%80%83%20IV%E2%80%83in%E2%80%83%20combating%E2%80%83%0Aneuronal%E2%80%83aging%EF%BC%BBJ%EF%BC%BD%EF%BC%8EAging%E2%80%83Dis%EF%BC%8C2022%EF%BC%8C13%EF%BC%886%EF%BC%89%EF%BC%9A%0A1845-1861%EF%BC%8E
24、熊亚茹,肖丽佳,谭满意,等.某灵芝孢子油软胶囊对小鼠抗疲劳作用[J].预防医学情报杂志,2023,39(10):1225-1229.熊亚茹,肖丽佳,谭满意,等.某灵芝孢子油软胶囊对小鼠抗疲劳作用[J].预防医学情报杂志,2023,39(10):1225-1229.
25、%E2%80%83%20IONITA%E2%80%83P%EF%BC%8EThe%E2%80%83chemistry%E2%80%83of%E2%80%83DPPH%C2%B7free%E2%80%83%20radical%E2%80%83and%E2%80%83%0Acongeners%EF%BC%BBJ%EF%BC%BD%EF%BC%8EInt%E2%80%83J%E2%80%83Mol%EF%BC%8C2021%EF%BC%8C22%EF%BC%884%EF%BC%89%EF%BC%9A1545%EF%BC%8E%E2%80%83%20IONITA%E2%80%83P%EF%BC%8EThe%E2%80%83chemistry%E2%80%83of%E2%80%83DPPH%C2%B7free%E2%80%83%20radical%E2%80%83and%E2%80%83%0Acongeners%EF%BC%BBJ%EF%BC%BD%EF%BC%8EInt%E2%80%83J%E2%80%83Mol%EF%BC%8C2021%EF%BC%8C22%EF%BC%884%EF%BC%89%EF%BC%9A1545%EF%BC%8E
26、ILYASOV%E2%80%83I%E2%80%83R%20%EF%BC%8C%20BELOBORODOV%E2%80%83V%E2%80%83L%20%EF%BC%8C%0ASELIVANOVA%E2%80%83%E2%80%83I%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8EABTS%2FPP%E2%80%83decolorization%E2%80%83%0Aassay%E2%80%83of%E2%80%83antioxidant%E2%80%83capacity%E2%80%83reaction%E2%80%83pathways%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0AInt%E2%80%83J%E2%80%83Mol%E2%80%83Sc%EF%BC%8C2020%EF%BC%8C21%EF%BC%883%EF%BC%89%EF%BC%9A1131%EF%BC%8EILYASOV%E2%80%83I%E2%80%83R%20%EF%BC%8C%20BELOBORODOV%E2%80%83V%E2%80%83L%20%EF%BC%8C%0ASELIVANOVA%E2%80%83%E2%80%83I%E2%80%83A%EF%BC%8Cet%E2%80%83al%EF%BC%8EABTS%2FPP%E2%80%83decolorization%E2%80%83%0Aassay%E2%80%83of%E2%80%83antioxidant%E2%80%83capacity%E2%80%83reaction%E2%80%83pathways%EF%BC%BBJ%EF%BC%BD%EF%BC%8E%0AInt%E2%80%83J%E2%80%83Mol%E2%80%83Sc%EF%BC%8C2020%EF%BC%8C21%EF%BC%883%EF%BC%89%EF%BC%9A1131%EF%BC%8E
1、广东省医院协会医院药学科研专项基金项目(YXKY202215);广东省医院药学研究基金项目(2021A16); 深圳市医疗卫生三名工程项目(NO:SZSM202301035)()
上一篇
下一篇
出版者信息








《广州医药》公众号
目录